Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion

A. Morganti, T. G. Pickering, J. A. Lopez-Ovejero, J. H. Laragh

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

In this study we examined the effects of the orally active angiotensin-converting enzyme inhibitor SQ 14225 (Captopril) on blood pressure, heart rate, plasma norepinephrine and epinephrine, PRA, aldosterone, cortisol, and serum potassium in 15 sodium-repleted hypertensive patients in the supine position and during 30 min of head-up tilt; in 3 patients the same investigations were repeated after sodium deprivation. On normal sodium intake, a short term treatment with SQ 14225, at average doses of 480 ± 60 mg/day, reduced mean supine blood pressure by 19 ± 3 mm Hg (P

Original languageEnglish
Pages (from-to)748-754
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume50
Issue number4
Publication statusPublished - 1980

Fingerprint

Enzyme inhibition
Supine Position
Captopril
Sodium
Head
Blood pressure
Enzymes
Blood Pressure
Aldosterone
Angiotensin-Converting Enzyme Inhibitors
Epinephrine
Hydrocortisone
Norepinephrine
Potassium
Heart Rate
Plasmas
Serum
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion. / Morganti, A.; Pickering, T. G.; Lopez-Ovejero, J. A.; Laragh, J. H.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 50, No. 4, 1980, p. 748-754.

Research output: Contribution to journalArticle

@article{a7f49b2426ff4b10a6f865f642e8a36c,
title = "Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion",
abstract = "In this study we examined the effects of the orally active angiotensin-converting enzyme inhibitor SQ 14225 (Captopril) on blood pressure, heart rate, plasma norepinephrine and epinephrine, PRA, aldosterone, cortisol, and serum potassium in 15 sodium-repleted hypertensive patients in the supine position and during 30 min of head-up tilt; in 3 patients the same investigations were repeated after sodium deprivation. On normal sodium intake, a short term treatment with SQ 14225, at average doses of 480 ± 60 mg/day, reduced mean supine blood pressure by 19 ± 3 mm Hg (P",
author = "A. Morganti and Pickering, {T. G.} and Lopez-Ovejero, {J. A.} and Laragh, {J. H.}",
year = "1980",
language = "English",
volume = "50",
pages = "748--754",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion

AU - Morganti, A.

AU - Pickering, T. G.

AU - Lopez-Ovejero, J. A.

AU - Laragh, J. H.

PY - 1980

Y1 - 1980

N2 - In this study we examined the effects of the orally active angiotensin-converting enzyme inhibitor SQ 14225 (Captopril) on blood pressure, heart rate, plasma norepinephrine and epinephrine, PRA, aldosterone, cortisol, and serum potassium in 15 sodium-repleted hypertensive patients in the supine position and during 30 min of head-up tilt; in 3 patients the same investigations were repeated after sodium deprivation. On normal sodium intake, a short term treatment with SQ 14225, at average doses of 480 ± 60 mg/day, reduced mean supine blood pressure by 19 ± 3 mm Hg (P

AB - In this study we examined the effects of the orally active angiotensin-converting enzyme inhibitor SQ 14225 (Captopril) on blood pressure, heart rate, plasma norepinephrine and epinephrine, PRA, aldosterone, cortisol, and serum potassium in 15 sodium-repleted hypertensive patients in the supine position and during 30 min of head-up tilt; in 3 patients the same investigations were repeated after sodium deprivation. On normal sodium intake, a short term treatment with SQ 14225, at average doses of 480 ± 60 mg/day, reduced mean supine blood pressure by 19 ± 3 mm Hg (P

UR - http://www.scopus.com/inward/record.url?scp=0018970848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018970848&partnerID=8YFLogxK

M3 - Article

C2 - 6245101

AN - SCOPUS:0018970848

VL - 50

SP - 748

EP - 754

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -